Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles | Zendy

David M. Livermore | Zendy; Shazad Mushtaq | Zendy; Danièle Meunier | Zendy; Katie L. Hopkins | Zendy; Robert Hill | Zendy; Rachael Adkin | Zendy; Aiysha Chaudhry | Zendy; Rachel Pike | Zendy; Peter Staves | Zendy; Neil Woodford | Zendy

Open Access

Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles

Author(s) -

David M. Livermore,

Shazad Mushtaq,

Danièle Meunier,

Katie L. Hopkins,

Robert Hill,

Rachael Adkin,

Aiysha Chaudhry,

Rachel Pike,

Peter Staves,

Neil Woodford

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx136

Subject(s) - microbiology and biotechnology , pseudomonas aeruginosa , klebsiella pneumoniae , stenotrophomonas maltophilia , biology , ceftazidime , enterobacteriaceae , agar dilution , tazobactam , efflux , antibiotics , antibiotic resistance , escherichia coli , imipenem , bacteria , minimum inhibitory concentration , gene , biochemistry , genetics

We assessed the activity of ceftolozane/tazobactam against consecutive isolates collected in the BSAC Bacteraemia Surveillance from 2011 to 2015 and against 'problem' isolates sent to the UK national reference laboratory from July 2015, when routine testing began.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research